rs201074393

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001008394.3(EID3):​c.214G>A​(p.Glu72Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00219 in 1,613,978 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E72V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 8 hom. )

Consequence

EID3
NM_001008394.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.81

Publications

5 publications found
Variant links:
Genes affected
EID3 (HGNC:32961): (EP300 interacting inhibitor of differentiation 3) Predicted to be involved in DNA repair. Located in nucleolus and nucleoplasm. Part of Smc5-Smc6 complex. [provided by Alliance of Genome Resources, Apr 2022]
TXNRD1 (HGNC:12437): (thioredoxin reductase 1) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes an ubiquitously expressed, cytosolic form of TrxR, which functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternative splicing, primarily at the 5' end, results in transcript variants encoding same or different isoforms, including a glutaredoxin-containing isoform that is predominantly expressed in testis. [provided by RefSeq, May 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.061716825).
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EID3NM_001008394.3 linkc.214G>A p.Glu72Lys missense_variant Exon 1 of 1 ENST00000527879.2 NP_001008395.1 Q8N140A0A140VJI9
TXNRD1NM_001093771.3 linkc.415-7142G>A intron_variant Intron 4 of 16 ENST00000525566.6 NP_001087240.1 Q16881-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EID3ENST00000527879.2 linkc.214G>A p.Glu72Lys missense_variant Exon 1 of 1 6 NM_001008394.3 ENSP00000435619.1 Q8N140
TXNRD1ENST00000525566.6 linkc.415-7142G>A intron_variant Intron 4 of 16 1 NM_001093771.3 ENSP00000434516.1 Q16881-1

Frequencies

GnomAD3 genomes
AF:
0.00102
AC:
156
AN:
152276
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000376
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00191
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000842
AC:
210
AN:
249276
AF XY:
0.000939
show subpopulations
Gnomad AFR exome
AF:
0.000517
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000232
Gnomad NFE exome
AF:
0.00165
Gnomad OTH exome
AF:
0.000991
GnomAD4 exome
AF:
0.00232
AC:
3386
AN:
1461702
Hom.:
8
Cov.:
30
AF XY:
0.00223
AC XY:
1621
AN XY:
727132
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33478
American (AMR)
AF:
0.000134
AC:
6
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000927
AC:
8
AN:
86256
European-Finnish (FIN)
AF:
0.000468
AC:
25
AN:
53398
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00291
AC:
3232
AN:
1111868
Other (OTH)
AF:
0.00164
AC:
99
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
233
466
699
932
1165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00102
AC:
156
AN:
152276
Hom.:
0
Cov.:
33
AF XY:
0.000766
AC XY:
57
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.000482
AC:
20
AN:
41480
American (AMR)
AF:
0.0000654
AC:
1
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4838
European-Finnish (FIN)
AF:
0.000376
AC:
4
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00191
AC:
130
AN:
68046
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000378
Hom.:
0
Bravo
AF:
0.000903
ExAC
AF:
0.000835
AC:
101
EpiCase
AF:
0.00169
EpiControl
AF:
0.00219

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 28, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.214G>A (p.E72K) alteration is located in exon 1 (coding exon 1) of the EID3 gene. This alteration results from a G to A substitution at nucleotide position 214, causing the glutamic acid (E) at amino acid position 72 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.43
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.021
T
Eigen
Benign
0.0072
Eigen_PC
Benign
-0.033
FATHMM_MKL
Benign
0.61
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.062
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L
PhyloP100
1.8
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.15
Sift
Benign
0.25
T
Sift4G
Benign
0.28
T
Polyphen
0.75
P
Vest4
0.29
MVP
0.49
MPC
0.68
ClinPred
0.13
T
GERP RS
2.7
PromoterAI
-0.013
Neutral
Varity_R
0.16
gMVP
0.32
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201074393; hg19: chr12-104697926; API